WRBY
Warby Parker Inc.
NYSE · USHealthcareMedical - Instruments & Supplies
$24.59-6.89%
Price as of Jul 20, 2026
WRBY growth
Warby Parker Inc. growth
Reported trailing growth, forward expectations and three-year compound growth rates.
Trailing growth
Year over year
- Revenue
- +12.0%
- EBITDA
- +97.2%
- EBIT
- +72.7%
- EPS
- +109.7%
- Free cash flow
- -8.3%
- Operating cash flow
- -2.1%
Forward estimates
- Revenue
- +18.2%
- EBITDA
- —
- EPS
- +4706.2%
Three-year CAGR
- Revenue
- +13.4%
- EBITDA
- +102.4%
- EBIT
- +82.3%
- Net income
- +108.0%
- EPS
- +107.9%
- Free cash flow
- +144.4%
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.